16 July 2026

Breast cancer PBS Pharmaceuticals

AstraZeneca announces new access program for cancer implant

16 July 2026

Pharmaceuticals Prostate cancer

Estradiol patches rival standard ADT in locally advanced prostate cancer

4 June 2026

Leukaemia PBS Pharmaceuticals

PBS listing opens access to breakthrough therapy

4 June 2026

ASCO pancreatic cancer Pharmaceuticals

Standing ovation at ASCO for cancer pill

21 May 2026

Drugs Pharmaceuticals TGA

Peptide craze sparks Lancet warning

23 April 2026

PBS Pharmaceuticals

Aussie-made hereditary angioedema therapy gains PBS listing

23 April 2026

Gastrointestinal cancer Pharmaceuticals

Imatinib improves outcomes in exon 9 GIST

26 March 2026

Chemotherapy Pharmaceuticals

Preventing chemotherapy-induced hand-foot syndrome

12 March 2026

Cancer Pharmaceuticals Public Health

Daily aspirin does not lower cancer risk in older adults

12 March 2026

Breast cancer Pharmaceuticals TGA

Combo therapy for breast cancer hiding in plain sight

12 March 2026

PBS Pharmaceuticals

Consolidated listing for combination immune checkpoint inhibitors

26 February 2026

Colorectal cancer Pharmaceuticals

Polypharmacy a problem for many CRC patients

26 February 2026

Pharmaceuticals Pregnancy TGA Women

Updates to the pregnancy prescribing list

12 February 2026

Cancer Gastroenterology Pharmaceuticals

PPI use not linked to stomach cancer, new study finds

4 December 2025

PBS Pharmaceuticals

Green light for first targeted therapy for relapsed myeloma

3 December 2025

PBS Pharmaceuticals

Frontline myeloma therapy lands on the PBS

3 December 2025

FDA Leukaemia Pharmaceuticals

Blood cancer round-up

20 November 2025

oncology Pharmaceuticals

Drug combo improves colorectal cancer survival

6 November 2025

PBS Pharmaceuticals

New PBS listing for front-line lymphoma therapy

6 November 2025

Cancer Clinical research Pharmaceuticals

More DOACs is not always better for minimising VTE risk